AzTrials
AzTrials

Bariatric Surgery CandidateNCT05987787

Suture Reinforcement to Reduce the Leak Rate After Sleeve Gastrectomy

An observational study of Bariatric Surgery Candidate and Obesity, Morbid, run by University of Foggia at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Staple line reinforcement (SLR) has been suggested as a mean of reducing the risk of sleeve leakage or bleeding. The aim of this study is to analyze if the suture reinforcement can be used to reduce the leakage rate after sleeve gastrectomy. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
laparoscopic sleeve gastrectomy without suture reinforcement and laparoscopic sleeve gastrectomy with suture reinforcement
Type of treatment
Surgery or procedure
How many people
33 participants
Where
1 siteItaly
Study dates
1 Jan 2022to 1 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Adult, Older adult

Study population: Body mass index (BMI) ≥35-39 kg/m2 with one obesity- associated co-morbidity or BMI≥40kg/m2, age ≥ 18 years. Before surgery, patients underwent a standardized psychological and physical evaluation which includes blood chemistry tests, chest x-rays, electrocardiogram and cardiological examinations, nutritional evaluation, esophagogastroduodenoscopy, spirometry and psychiatric evaluation .

Who may be able to join

  • BMI>40 kg/m2
  • BMI>35 kg/m2with at least one associated major comorbidity

Who cannot join

  • secondary obesity due to endocrine and psychological disorders
  • patients under antiaggregant and anticoagulant therapy
  • re-do surgery.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • University of Foggia

    Foggia, 71122

Other trials in Italy

About this study

Official title: Staple-line Suture Reinforcement: Could it Help Contain the Leak?

Staple line reinforcement (SLR) has been suggested as a mean of reducing the risk of sleeve leakage or bleeding. The aim of this study is to analyze if the suture reinforcement can be used to reduce the leakage rate after sleeve gastrectomy.

Being tested
laparoscopic sleeve gastrectomy without suture reinforcement, laparoscopic sleeve gastrectomy with suture reinforcement
Medical subject headings
Obesity, Morbid, Anastomotic Leak, Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopic sleeve gastrectomy without suture reinforcementProcedure or surgery

    The procedure begins by dissecting the small branches of the gastroepiploic arch 6 cm from the pylorus. The dissection continues along the great curvature of the stomach, remaining very close to the gastric wall, up to the short gastric vessels which are also dissected. The stomach is then raised to expose its posterior wall and the adhesions are lysed. His angle is fully mobilized and the left diaphragmatic pillar exposed. The gastric tubule is created on the guide of a 40 F Bugie using mechanical suturing machines with charges of different thickness depending on the thickness of the gastric wall. At this point the bougie is removed and the resected stomach is extracted from the abdomen through the mesogastric access.

  • laparoscopic sleeve gastrectomy with suture reinforcementProcedure or surgery

    The procedure begins by dissecting the small branches of the gastroepiploic arch 6 cm from the pylorus. The dissection continues along the great curvature of the stomach, remaining very close to the gastric wall, up to the short gastric vessels which are also dissected. The stomach is then raised to expose its posterior wall and the adhesions are lysed. His angle is fully mobilized and the left diaphragmatic pillar exposed. The gastric tubule is created on the guide of a 40 F Bugie using mechanical suturing machines with charges of different thickness depending on the thickness of the gastric wall. At this point the bougie is removed and the resected stomach is extracted from the abdomen through the mesogastric access. At this point, it is applied running seromuscular stitches at the proximal third of the stapled line using unidirectional 2/0 barbed sutures to invaginate the staple line completely.

Study groups in NCT05987787
Study groupRoleWhat they receive
Obese patients underwent laparoscopic sleeve gastrectomy with suture reinforcementLaparoscopic sleeve gastrectomy running seromuscular stitches at the proximal third of the stapled line using unidirectional 2/0 barbed sutures to invaginate the staple line completely.
Receives: Procedure: laparoscopic sleeve gastrectomy with suture reinforcement
Obese patients underwent laparoscopic sleeve gastrectomy without suture reinforcementLaparoscopic sleeve gastrectomy without staple line reinforcement.
Receives: Procedure: laparoscopic sleeve gastrectomy without suture reinforcement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the importance of staple line reinforcement

    reduction of the leak rate in the suture group

    Measured: 1 year

  2. the importance of staple line reinforcement

    the differences of operative time between two groups

    Measured: During Surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start1 Jan 2022
  3. Primary completion31 Dec 2022
  4. Study completion1 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05987787
Sponsor's protocol ID
8
Status last verified
Aug 2023
First submitted
26 Jul 2023
Last updated
14 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bariatric Surgery Candidate and Obesity, Morbid, run by University of Foggia at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the importance of staple line reinforcement (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in